Article Details

Sutro Biopharma retains stock target with Buy rating on key advancements - Investing.com

Retrieved on: 2024-10-11 15:34:53

Tags for this article:

Click the tags to see associated articles and topics

Sutro Biopharma retains stock target with Buy rating on key advancements - Investing.com. View article details on hiswai:

Excerpt

Recent InvestingPro data provides additional context to Sutro Biopharma's (NASDAQ:STRO) financial position and market performance. Despite the ...

Article found on: www.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up